Logotype for Marfrig Global Foods SA

Marfrig Global Foods (MBRF3) Q1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Marfrig Global Foods SA

Q1 2026 earnings summary

20 May, 2026

Executive summary

  • Net sales reached BRL 3.49 billion in Q1, up 6.9% year-over-year, despite a 5.8% decline in sales volume due to tight cattle supplies and extended feeding periods.

  • Achieved net income of R$111 million, up 26.8% year-over-year, with net revenue of R$39.5 billion and adjusted EBITDA of R$3.1 billion, reflecting robust performance and disciplined execution across all segments.

  • Strategic investments in China and the Middle East, including the acquisition of the Henan plant and creation of Sadia Halal, are expected to drive sustainable growth and global competitiveness.

  • Integration of Marfrig and BRF operations advanced, capturing R$126 million in synergies and progressing on the MBRF+ efficiency program with R$296 million in savings.

  • Strong beef and poultry demand persisted in both domestic and export markets, with notable growth in exports to China and the Middle East.

Financial highlights

  • Net revenue was R$39,453 million, down 0.1% year-over-year, with 46% from North America, 16% from South America, and 38% from BRF.

  • Adjusted EBITDA reached R$3,096 million (7.8% margin), down 3.2% year-over-year, mainly due to BRF seasonality.

  • Inventory and biological assets consumed BRL 1.1 billion in working capital, mainly due to export focus and feedlot expansion.

  • CapEx for Q1 was BRL 1.2 billion, with full-year guidance around BRL 5 billion.

  • Free cash flow was negative R$1,262 million, reflecting seasonal working capital consumption and inventory build-up.

Outlook and guidance

  • Management expects Q2 results to improve over last year, with margins anticipated to be no worse than the prior year.

  • Management expects investments in new geographies and integration synergies to yield increasing returns throughout 2026.

  • Inventory levels are expected to normalize by year-end, gradually releasing working capital.

  • No major supply/demand imbalances are forecast for poultry; 2026 supply growth is projected at 2%.

  • CapEx will accelerate in Q2, with investments adjusted based on cash generation.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more